Commerce Bank’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.89M Buy
32,030
+9,426
+42% +$1.44M 0.02% 364
2025
Q4
$3.12M Buy
22,604
+461
+2% +$60.4K 0.02% 397
2025
Q3
$2.84M Buy
22,143
+358
+2% +$43.7K 0.02% 428
2025
Q2
$2.64M Sell
21,785
-2,028
-9% -$229K 0.02% 447
2025
Q1
$2.65M Buy
23,813
+2,581
+12% +$275K 0.02% 431
2024
Q4
$2.07M Sell
21,232
-405
-2% -$43.2K 0.01% 475
2024
Q3
$2.49M Buy
21,637
+82
+0.4% +$9.3K 0.02% 449
2024
Q2
$2.29M Sell
21,555
-157
-0.7% -$15.8K 0.01% 451
2024
Q1
$2.1M Sell
21,712
-614
-3% -$63K 0.01% 464
2023
Q4
$2.25M Sell
22,326
-6
-0% -$579 0.02% 448
2023
Q3
$2.27M Buy
22,332
+307
+1% +$31.2K 0.02% 432
2023
Q2
$2.22M Sell
22,025
-453
-2% -$45.3K 0.02% 433
2023
Q1
$2.07M Buy
22,478
+34
+0.2% +$2.97K 0.02% 432
2022
Q4
$2.04M Sell
22,444
-1,060
-5% -$89.3K 0.02% 433
2022
Q3
$1.79M Buy
23,504
+1,050
+5% +$87K 0.02% 450
2022
Q2
$1.9M Buy
22,454
+210
+0.9% +$18.4K 0.02% 446
2022
Q1
$1.95M Sell
22,244
-629
-3% -$54.5K 0.01% 467
2021
Q4
$2M Sell
22,873
-1,883
-8% -$156K 0.01% 465
2021
Q3
$2.02M Sell
24,756
-1,189
-5% -$107K 0.01% 466
2021
Q2
$2.37M Buy
25,945
+95
+0.4% +$8.46K 0.02% 432
2021
Q1
$2.21M Buy
25,850
+856
+3% +$76.8K 0.02% 430
2020
Q4
$2.36M Sell
24,994
-109
-0.4% -$9.53K 0.02% 412
2020
Q3
$2.18M Sell
25,103
-10,088
-29% -$874K 0.02% 389
2020
Q2
$3.07M Buy
35,191
+11,514
+49% +$994K 0.03% 341
2020
Q1
$1.95M Sell
23,677
-218
-0.9% -$19.4K 0.02% 358
2019
Q4
$2.26M Sell
23,895
-1,656
-6% -$149K 0.02% 375
2019
Q3
$2.22M Sell
25,551
-968
-4% -$86.9K 0.02% 372
2019
Q2
$2.42M Sell
26,519
-3,181
-11% -$269K 0.03% 295
2019
Q1
$2.56M Buy
29,700
+695
+2% +$55.8K 0.03% 271
2018
Q4
$2.23M Sell
29,005
-655
-2% -$51K 0.03% 275
2018
Q3
$2.29M Sell
29,660
-1,888
-6% -$140K 0.03% 291
2018
Q2
$2.14M Sell
31,548
-366
-1% -$25.3K 0.03% 286
2018
Q1
$2.31M Buy
31,914
+662
+2% +$50.4K 0.03% 272
2017
Q4
$2.35M Buy
31,252
+741
+2% +$55.9K 0.03% 273
2017
Q3
$2.35M Sell
30,511
-1,383
-4% -$104K 0.03% 264
2017
Q2
$2.38M Sell
31,894
-3,152
-9% -$223K 0.03% 253
2017
Q1
$2.33M Sell
35,046
-3,108
-8% -$207K 0.03% 253
2016
Q4
$2.49M Sell
38,154
-4,157
-10% -$270K 0.04% 239
2016
Q3
$2.99M Sell
42,311
-1,302
-3% -$94.9K 0.05% 227
2016
Q2
$3.22M Sell
43,613
-855
-2% -$59.1K 0.05% 227
2016
Q1
$2.89M Buy
44,468
+4,382
+11% +$298K 0.05% 226
2015
Q4
$3.09M Buy
40,086
+376
+0.9% +$29.9K 0.05% 217
2015
Q3
$3.27M Sell
39,710
-1,709
-4% -$152K 0.06% 220
2015
Q2
$3.65M Sell
41,419
-2,693
-6% -$247K 0.06% 213
2015
Q1
$3.9M Buy
44,112
+2,933
+7% +$260K 0.06% 208
2014
Q4
$3.42M Sell
41,179
-2,203
-5% -$183K 0.05% 218
2014
Q3
$3.66M Buy
43,382
+660
+2% +$53.4K 0.06% 208
2014
Q2
$3.46M Buy
42,722
+518
+1% +$40.7K 0.06% 215
2014
Q1
$3.21M Buy
42,204
+2,040
+5% +$149K 0.05% 218
2013
Q4
$2.89M Buy
40,164
+2,556
+7% +$178K 0.05% 223
2013
Q3
$2.58M Sell
37,608
-1,856
-5% -$123K 0.05% 222
2013
Q2
$2.5M Buy
+39,464
New +$2.57M 0.05% 222

Other funds holding NVS

Commerce Bank's NVS Position: Q1 2026 in Review

Commerce Bank increased its Novartis (NVS) stake by 42% in Q1 2026, buying an estimated $1.44M and bringing the position to 32,030 shares worth $4.89M. The position accounts for 0.02% of the portfolio, ranked #364.

Commerce Bank first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Commerce Bank held 32,030 shares of Novartis worth $4.89M as of Q1 2026.
  • Commerce Bank bought 9,426 Novartis shares in Q1 2026, an estimated $1.44M.
  • Novartis made up 0.02% of Commerce Bank's portfolio in Q1 2026, its #364 holding.
  • Commerce Bank first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Commerce Bank's 13F filing for Q1 2026, filed 11 May 2026.